Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Primary Data Collection Study to Compare the Lung Function in the Adult Severe Asthma Patients Who Start Biologics Treatment and Who do Not Start, After Two-year Follow-up

NCT04808518 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04808518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04808518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Primary Data Collection Study to Compare the Lung Function in the Adult Severe Asthma Patients Who Start Biologics Treatment and Who do Not Start, After Two-year Follow-up
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
December 10, 2019
Completion date
November 27, 2023
Enrollment
74 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

asthma